Treatment of distal subungual onychomycosis with a topical preparation of urea, propylene glycol and lactic acid: Results of a 24-week, double-blind, placebo-controlled study

Mycoses

Volumn 55, Issue 6, 2012, Pages 532-540

  Emtestam, L ^a   Kaaman, T ^b   Rensfeldt, K ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Mykolab   (Sweden)

^c NONE

Author keywords

K101; Onychomycosis; Placebo

Indexed keywords

K 101; PLACEBO; TOPICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIFUNGAL ACTIVITY; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; ARTICLE; BEDTIME DOSAGE; CONTROLLED STUDY; DISTAL SUBUNGUAL ONYCHOMYCOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAIL; ONYCHOLYSIS; ONYCHOMYCOSIS; PAIN; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TOPICAL TREATMENT; TRICHOPHYTON MENTAGROPHYTES INFECTION; TRICHOPHYTON RUBRUM INFECTION;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; FOOT DERMATOSES; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; NAILS; ONYCHOMYCOSIS; PROPYLENE GLYCOL; UREA; YOUNG ADULT;

EID: 84867497316     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2012.02215.x     Document Type: Article

References (30)

1. Elewski BE, Charif MA. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol 1997; 133: 1172-3.
2. Heikkila H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995; 133: 699-703.
3. Ghannoum MA, Hajjeh RA, Scher R et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 2000; 43: 641-8.
4. Gupta AK, Konnikov N, MacDonald P. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol 1998; 139: 665-71.
5. Faergemann J, Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol 2003; 149: S1-4.
6. De Berker D. Fungal nail disease. New Engl J Med 2009; 360: 2108-16.
7. O'Sullivan DP, Needham CA, Bangs A et al. Postmarketing surveillance of oral terbinafine in the UK: report of a large cohort study. Br J Clin Pharmacol 1996; 42: 559-65.
8. Crawford F, Hollis S. Topical treatment for fungal infections of the skin and nails of the foot. Cochrane Database Sys Rev 2007 DOI: 10.1002/14651858.CD001434.pub2.
9. Farber EM, South DA. Urea ointment in the nonsurgical avulsion of nail dystrophies. Cutis 1978; 22: 689-92.
10. South DA, Farber EM. Urea ointment in the nonsurgical avulsion of nail dystrophies--a reappraisal. Cutis 1980; 25: 609-12.
11. Goldsmith LA. Propylene glycol. Int J Dermatol 1978; 17: 703-5.
12. Gamborg Nielsen P. Dermatophyte infections in hereditary palmo-planter keratoderma. Dermatologica 1984; 168: 238-41.
13. Nielsen PG. The importance of the vehicle in the treatment of dermatophytosis in hereditary palmo-plantar keratoderma. Mykosen 1984; 27: 227-30.
14. Faergemann J, Bernander S. The activity in vitro of five different antimycotics against pityrosporum orbiculare. Acta Derm Venereol 1979; 59: 521-4.
15. Faergemann J, Fredriksson T. Propylene glycol in the treatment of tinea versicolor. Acta Derm Venereol 1979; 60: 92-3.
16. Kinnunen T, Koskel M. Antibacterial and antifungal properties of propylene glycol, hexylene glycol, and 1, 3-butylene glycol in vitro. Acta Derm Venereol 1991; 71: 148-50.
17. Baran R, Maibach HI. Skin care products for normal, dry and greasy skin. In: Baran R, Maibach HI (eds), Textbook of Cosmetic Dermatology. London: Taylor and Francis, 1989: 96-143.
18. Faergemann J, Swanbeck G. Treatment of onychomycosis with a propylene glycol-urea-lactic acid solution. Mycoses 1989; 32: 536-40.
19. Rippon JW. Medical Mycology, Chapter 8 Dermatophytosis. Philadelphia: W.B.Saunders Company, 1988.
20. Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol 2000; 43: S70-80.
21. Elewski BE, Ghannoum MA, Mayser P et al. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs. J Eur Acad Dermatol Venereol 2011; doi: 10.1111/j.1468-3083.2011.04373.x. [Epub ahead of print].
22. Lauharanta J. Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly. Clin Exp Dermatol 1992; 17: S41-3.
23. Drake LA, Shear NH, Arlette JP et al. Oral terbinafine in the treatment of toenail onychomycosis: North American multicentre trial. J Am Acad Dermatol 1997; 37: 740-5.
24. Evans EGV, Sigurgeirsson B. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. BMJ 1999; 318: 1031-5.
25. Heikkila H, Stubb S. Long-term results in patients with onychomycosis treated with terbinafine or itraconazole. Br J Dermatol 2002; 146: 250-3.
26. Sigurgeirsson B, Olafsson JH, Steinsson J et al. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-Year blinded prospective follow-up study. Arch Dermatol 2002; 138: 353-7.
27. Warshaw EM, Fett DD, Bloomfield HE et al. Pulse versus continuous terbinafine for onychomycosis: a randomised, double-blind controlled trial. J Am Acad Dermatol 2005; 53: 578-84.
28. Shenoy MM, Teerthanath S, Karnaker VK et al. Comparison of potassium hydroxide mount and mycological culture with histopathologic examination using periodic acid-Schiff staining of the nail clippings in the diagnosis of onychomycosis. Indian J Dermatol Venereol Leprol 2008; 74: 226-9.
29. Epstein E. Fungus-free versus disease-free nails. J Am Acad Dermatol 2004; 50: 151-2.
30. Nolting S. Non-traumatic removal of the nail and simultaneous treatment of onychomycosis. Dermatologica 1984; 169: S117-20.